IRMD vs PAHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 05, 2026

IRMD

48.2
AI Score
VS
IRMD Wins

PAHC

28.2
AI Score

Investment Advisor Scores

IRMD

48score
Recommendation
HOLD

PAHC

28score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric IRMD PAHC Winner
Forward P/E 41.1523 13.8313 PAHC
PEG Ratio 4.46 1.6791 PAHC
Revenue Growth 0.3% 4.8% PAHC
Earnings Growth -9.3% 24.6% PAHC
Tradestie Score 48.2/100 28.2/100 IRMD
Profit Margin 26.7% 6.6% IRMD
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL IRMD

Relative Price Performance (Last 90 Days)

IRMD 1M: -6.0% · 3M: -14.6% PAHC 1M: +6.7% · 3M: +15.3%

Current Technical Phase

IRMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 30

RSI (14): 29.8 · Price: $82.18

PAHC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.0 · Price: $36.06

Fundamentals Snapshot

Metric IRMD PAHC
Market Cap
Forward P/E 34.0 10.9
Trailing P/E 47.2 15.1
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.8% 0.3%
Operating Margin 0.3% 0.1%
EPS 1.77 2.43
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, IRMD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.